Bucking Landmark U.S. Recommendation, Oncologist Urges PSA Screening

Bucking Landmark U.S. Recommendation, Oncologist Urges PSA Screening
Despite a United States Preventive Services Task Force (USPSTF) 2012 conclusion that routine tests for prostate cancer are unnecessary, a prominent oncologist believes such screenings should be encouraged. Vladimir Ioffe, MD, a radiation oncologist with 21st Century Oncology, said prostate-specific antigen (PSA) screenings ought to be recommended for African-American males, men with a family history of the disorder, and healthy males ages 70–80. Discontinuing such tests could result in more than 6,000 prostate cancer-related deaths annually in the United States, he said. Ioffe’s study was completed in collaboration with Navin Shah, MD; Thomas Huebner, MD, and Ivelina Hristova, BA. ”Our study shows that the current USPSTF prostate cancer screening recommendations are harmful and result in later-stage prostate cancer detection,” Ioffe said in a press release. “We are seeing more late-stage diagnoses with more aggressive prostate cancer and in non-curable stages. We strongly believe that PSA-based prostate cancer screening should be cleared, recommended, and endorsed, especially for high-risk men.” He said that since the task force’s announcement, there has been a 9% rise in diagnoses of aggressive disease. This suggests that a lack of screening prevented earlier ca
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *